01
AAV Vector Science
Focus on adeno-associated virus platforms for targeted gene delivery, informed by years of translational research and clinical observation.
Physician-led · Research-informed · Invitation only
Medicine,
rewritten at the molecular level.
A private, physician-led platform for advanced AAV gene therapy research and structured longevity medicine—with continuous clinical oversight.
Physician-led
AAV research focus
Invitation only
Explicit regulatory framing
Our premise
The next frontier of medicine is not more noise. It is precision, governance and evidence.
Triple Helix Science brings molecular research into a disciplined, physician-led framework—built for careful inquiry, measured observation and responsible progress.
Our approach
Structured science. Continuous clinical oversight.
Unlike promotional longevity clinics, we operate as a physician-led research platform. Every engagement begins with rigorous assessment, clear jurisdictional boundaries, and continuous clinical oversight — not marketing claims.
02
Multi-Gene Research
Investigation of coordinated gene approaches, including pathways related to cellular resilience, cognitive function and metabolic support.
03
Physician Oversight
All clinical activity is directed by licensed physicians with extensive experience in interventional and regenerative medicine.
04
Measured Outcomes
Emphasis on structured monitoring, biomarker tracking and transparent documentation of clinical observations over time.
37+
Years of medical experience
400+
Patients treated across clinical specialties and settings
50+
Peer-reviewed publications
Important notice.
The therapies and protocols discussed on this site are investigational or provided in specific clinical contexts outside the United States.
They are not approved by the U.S. Food and Drug Administration (FDA) for the prevention, treatment or cure of any disease.
Individual results vary. Participation is by private introduction only and subject to medical suitability and local regulatory frameworks.
Scientific foundation
From interventional oncology to molecular medicine.
Decades of interventional oncology and image-guided procedure experience inform a careful AAV-focused approach — distinct from plasmid or consumer longevity products.
Interventional Background
Extensive work in image-guided oncology, including pioneering contributions to percutaneous ablation techniques, provides the clinical foundation for later translational efforts.
Vector Design & Delivery
Ongoing focus on AAV platform characteristics, safety considerations and targeted delivery strategies within regulated clinical environments.
Translational Observation
Clinical experience across multiple jurisdictions informs protocol design, monitoring frameworks and long-term follow-up practices.
Leadership
Dr. Patrick E. Sewell, MD
Founder · Chief Executive Officer · Chief Scientist
Dr. Sewell brings more than three decades of medical practice spanning interventional radiology, oncology and regenerative research. His formal training includes internal medicine, diagnostic radiology, interventional radiology and cross-sectional imaging.
He has contributed to early developments in image-guided cancer procedures and later directed substantial clinical work involving AAV-based gene delivery across international settings. His published research exceeds fifty peer-reviewed papers.
At Triple Helix Science he leads the scientific and clinical direction of the platform, with particular attention to protocol integrity, physician governance and responsible innovation.
Selected appearances
Conversations on gene therapy, longevity and clinical science.
YouTube
A New Era Against Cancer, Dementia & Aging
Extended conversation on AAV gene therapy, Klotho, Follistatin and clinical observations. Sober Head Podcast.
Watch interview →YouTube
Gene Therapy for Dementia and Longevity
Discussion with Robert Lufkin MD on hTERT, Klotho and translational gene therapy approaches.
Watch interview →YouTube
The Future of Cancer Treatment
Conversation on interventional oncology, image-guided procedures and the transition into gene therapy.
Watch interview →Private onboarding
Three simple steps.
A short guided profile gives us enough context for a useful first conversation. No medical records are required. Access remains by private introduction only.
01
Guided profile
Five short sections about goals, location and priorities.
02
Private introduction
A confidential conversation to assess suitability and fit.
03
Clear next steps
If aligned, we outline pathway, timeline and governance.
Step 1 of 5
20%
Important Legal & Regulatory Information
Please read the following carefully. By accessing or using this website you acknowledge that you have read, understood and agree to the statements below.
1. Investigational Status
The gene therapy approaches, protocols and related services described on this website are investigational in nature or are offered only in specific clinical contexts outside the United States. They have not been approved by the U.S. Food and Drug Administration (FDA) for the prevention, treatment, mitigation or cure of any disease or condition.
No statement on this website should be interpreted as a claim that any therapy is safe, effective or approved for any particular use by the FDA or any other regulatory authority.
2. No Medical Advice
Content on this website is provided for general informational purposes only. It does not constitute medical advice, diagnosis, treatment recommendation or a solicitation to engage in any particular medical service. Always consult a qualified, licensed physician regarding any medical condition or treatment decision.
3. Individual Results Vary
Clinical observations and published research referenced on this site reflect individual or limited-group experiences. Outcomes differ substantially between individuals. Past observations do not predict future results for any person.
4. Jurisdictional Limitations
Availability of any clinical service depends on local laws, regulations and professional licensing requirements. Triple Helix Science does not offer or promote services that would violate the laws of the visitor’s country of residence. Access is by private introduction only and subject to medical suitability assessment.
5. Physician-Led Governance
All clinical activities associated with the platform are directed by licensed physicians. Treating clinicians retain full responsibility for medical decision-making, informed consent and patient care within their respective jurisdictions.
6. Limitation of Liability
To the fullest extent permitted by applicable law, Triple Helix Science, its officers, directors, employees, consultants and affiliates disclaim all liability for any direct, indirect, incidental, consequential or special damages arising from the use of this website or reliance on any information contained herein.
7. Contact for Regulatory Inquiries
For questions regarding the regulatory status of any referenced activity, please contact us at contact@triplehelix.to.